The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab. uri icon

Overview

authors

  • Kreuzer, Karl-Anton
  • Furman, Richard R
  • Stilgenbauer, Stephan
  • Dubowy, Ronald L
  • Kim, Yeonhee
  • Munugalavadla, Veerendra
  • Lilienweiss, Esther
  • Reinhardt, Hans Christian
  • Cramer, Paula
  • Eichhorst, Barbara
  • Hillmen, Peter
  • O'Brien, Susan M
  • Pettitt, Andrew R
  • Hallek, Michael

publication date

  • August 19, 2019

Research

keywords

  • Abnormal Karyotype
  • Antineoplastic Combined Chemotherapy Protocols
  • Leukemia, Lymphocytic, Chronic, B-Cell

Identity

PubMed Central ID

  • PMC7214265

Scopus Document Identifier

  • 85070812697

Digital Object Identifier (DOI)

  • 10.1038/s41375-019-0533-6

PubMed ID

  • 31427720

Additional Document Info

volume

  • 34

issue

  • 1